Oculis Holding AG

OCS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$11.89+5.13%

2026-08-03

Financials

Valuation Metrics

Oculis Holding AG's Market Cap is $718M. At end of 2025 it was $1.07B. Ranked #2648 of 3,112 in US market (top 85%), #1121 of 1,445 on NASDAQ (top 78%), #209 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 78%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$718M	US#2,648/3,112 Sec#209/269
Revenue	$607701.00	US#2,967/3,112 Sec#201/269
Net Income	$-115M	US—/3,112 Sec—/269
Total Assets	$307M	US#2,888/3,112 Sec#207/269
Net Assets	$247M	US#2,643/3,112 Sec#176/269
Value
P/B	2.90x	US#1,636/3,112 Sec#83/269
FCF Yield	-10.61%	US—/3,112 Sec—/269
Profitability
ROE	-46.35%	US#2,726/3,112 Sec#168/269
ROA	-37.35%	US#2,915/3,112 Sec#184/269
Op. Margin	-16740.94%	US#2,964/3,112 Sec#200/269
Revenue Growth	-100.00%	US#2,948/3,112 Sec#190/269
Financial Health
Debt Ratio	24.08%	US#258/3,112 Sec#85/269
Total Debt	$3M	US#2,887/3,112 Sec#229/269
FCF	$-76M	US#2,533/3,112 Sec#132/269
Cash	$81M	US#2,332/3,112 Sec#189/269
Current Ratio	5.18x	US#453/3,112 Sec#141/269
Performance
1Y Return	-32.82%	US#2,803/3,112 Sec#231/269
1M Return	-15.79%	US#2,843/3,112 Sec#210/269
From 52W High	-65.52%	US#2,985/3,112 Sec#248/269
1Y MDD	-67.20%	US#2,872/3,112 Sec#240/269
Trading
Volume	281,276 shares	US#2,456/3,112 Sec#239/269
Trading Value	$3M	US#2,789/3,112 Sec#230/269
Per Share
EPS	$-1.98	US—/3,112 Sec—/269
BPS	$3.94	US#2,316/3,112 Sec#147/269